Medicine, initiated in 2019 a series of recorded discussions with leaders in nuclear medicine
and molecular imaging. For this issue, he talked with Elisabeth de Vries, MD, PhD, a …

Medicine, recently initiated a series of recorded discussions with leaders in nuclear
medicine and molecular imaging. The first of these, conducted on September 25, 2018, with …

Simon R. Cherry, PhD, is Distinguished Professor of Biomedical Engineering at the
University of California, Davis (UC Davis), and has received international recognition for …

Nuclear Medicine and a professor at the David Geffen School of Medicine at UCLA, talked
with Kalevi Kairemo, MD, PhD, MSc (Eng), about his career in pioneering novel radiolabeled …

Dear editor, Animal experiments are vitally important for evaluation of newly developed
nuclear tracers for imaging and therapy of cancers and cannot (yet) be adequately replaced …

Dear editor, Animal experiments are vitally important for evaluation of newly developed
nuclear tracers for imaging and therapy of cancers and cannot (yet) be adequately replaced …

Conclusion: Highlights in Oncology I see a growing potential for targeted radiotherapy with
new natural and artificial carriers. We will see an abundance of agents that target a variety of …

Medicine includes a report of a promising agent for the radiopharmaceutical therapy of
metastatic melanoma (1). The report is provocative for several reasons: it provides a …

Lisa Bodei, MD, PhD, from Memorial Sloan Kettering Cancer Center (New York, NY), and
Johannes Czernin, MD, from the David Geffen School of Medicine at the University of …

—Dennis Gabor The sensitivity of mammography in detecting breast abnormalities is close
to 90%; the specificity in detecting breast cancer is, conversely, as low as 50%. In current …